Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:51 AM
Ignite Modification Date:
2025-12-25 @ 4:51 AM
NCT ID:
NCT03348618
Eligibility Criteria:
Inclusion Criteria:
* Male and female children, 4-16 years of age
* Diagnosis of moderate to severe PANS based on accepted criteria
* Must be willing to follow study procedures and comply with wash-out period
* If using prophylactic antibiotics, must be on stable dose for 3 months
Exclusion Criteria:
* History of rheumatic fever, including Sydenham chorea (the neurologic manifestation)
* Previous IVIG therapy within the last 6 months
* Allergic reactions to blood products
* Patients who, in the investigator's opinion, might not be suitable for the trial.
* Steroid use
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
4 Years
Maximum Age:
16 Years
Study:
NCT03348618
Study Brief:
Protocol Section:
NCT03348618